Fundraising Fox
/Companies
Sign in

Tenpoint Therapeutics

Warren, US · Founded 2019 · 132 employees on LinkedIn · 5 known investors

Find your way into Tenpoint Therapeutics

Sign up to see every warm intro you have to Tenpoint Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tenpoint Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.

BiotechDigital HealthHealthtechLongevityMedical Devices

Founders & leadership

HBHENRIC BJARKE
HENRIC BJARKEChief Executive OfficerHenric Bjarke brings more than 20 years of executive leadership in pharmaceutical and biotechnology companies, including roles at Inozyme Pharma, Ophthotech, Alexion Pharmaceuticals, OSI Eyetech, and Pharmacia, where he worked on commercial strategy and product launches in ophthalmology and specialty pharma. He has led teams across North America and Europe and has experience raising capital for drug development and commercialization.

Investors · 5

F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M

How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us

Qiming Venture Partners USAlisted by Qiming Venture Partners USACambridge

How we know: Qiming Venture Partners USA's portfolio page · Not right? Tell us

Sofinnova Partnerslisted by Sofinnova PartnersParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · sofinnovapartners.com · open dataset · 5k.vc investor directory · Not right? Tell us

Qiming Venture PartnersreportedBeijing

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$235M disclosed across 1 of 3 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 2

MyeyedrMyEyeDr. is an optometry practice network providing vision care services across the United States. The company prioritizes community engagement through volunteer eye care services, medical missions, and partnerships with local organizations.
OcumetraOcumetra develops data science and business intelligence tools focused on myopia management and eye health for eye care professionals, including optometrists and ophthalmologists. The company creates clinical analytics platforms to help improve patient outcomes in childhood myopia management.

Companies working in the same space as Tenpoint Therapeutics.

In the news

Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform | Eye Care Network - Ophthalmology Times Europeophthalmologytimes.com · Aug 2026Company News & Press | Tenpoint Therapeutics™tenpointtherapeutics.com · Apr 2026Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™ - BioSpacebiospace.com · Jan 2026Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™finance.yahoo.com · Jan 2026Tenpoint Therapeutics Raises $235M Through Series B and Credit Facilityfinsmes.com · Jan 2026

Frequently asked questions

What does Tenpoint Therapeutics do?
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.
Who are Tenpoint Therapeutics's investors?
Tenpoint Therapeutics's investors include AdBio partners, F-Prime Capital, Qiming Venture Partners USA, Sofinnova Partners, Qiming Venture Partners.
How much funding has Tenpoint Therapeutics raised?
Tenpoint Therapeutics has disclosed $235M raised across 1 of its 3 known rounds.
Where is Tenpoint Therapeutics headquartered?
Tenpoint Therapeutics is headquartered in Warren, US.